Rain Ivf And Women Hospital Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 4 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.02 Cr
- Revenue Growth %
- Total Assets %
About Rain Ivf And Women Hospital
Rain Ivf And Women Hospital Private Limited (RIAWHPL) is a Private Limited Indian Non-Government Company incorporated in India on 27 November 2020 (Four years and two months 28 days old ). Its registered office is in Aurangabad, Maharashtra, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹2.02 Cr.
Surykant Pophale and Poonam Kunte serve as directors at the Company.
Company Details
- Location
Aurangabad, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U85300MH2020PTC350887
- Company No.
350887
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Nov 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Rain Ivf And Women Hospital?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Surykant Pophale  | Director | 27-Nov-2020 | Current |
| Poonam Kunte | Director | 27-Nov-2020 | Current |
Financial Performance of Rain Ivf And Women Hospital.
Rain Ivf And Women Hospital Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Rain Ivf And Women Hospital?
Unlock access to Rain Ivf And Women Hospital's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹20.18 M
₹0
Charges Breakdown by Lending Institutions
- Others : 2.02 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 14 Jul 2022 | Others | ₹2.02 Cr | Open |
How Many Employees Work at Rain Ivf And Women Hospital?
Rain Ivf And Women Hospital has a workforce of 0 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rain Ivf And Women Hospital, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rain Ivf And Women Hospital's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.